Showing results (271-280 of 312) with videos related to

Sort By:
Pageof 32
British Journal of Haematology|August 8, 2006
Absolute lymphocyte count predicts overall survival in follicular lymphomasMustaqeem Siddiqui, Kay Ristow, Svetomir N Markovic, et al.
Small (Weinheim an Der Bergstrasse, Germany)|August 22, 2024
Epitaxy of GaSe Coupled to Graphene: From In Situ Band Engineering to Photon SensingJonathan Bradford, Benjamin T Dewes, Mustaqeem Shiffa, et al.
Retina (Philadelphia, Pa.)|July 14, 2012
A factor found in the IgG fraction of serum of patients with paraneoplastic bilateral diffuse uveal melanocytic proliferation causes proliferation of cultured human melanocytesSarah L Miles, Richard M Niles, Sean Pittock, et al.
JMIR Research Protocols|April 24, 2024
Real-World Registry on the Pharmacotherapy of Multiple Myeloma and Associated Renal and Pulmonary Impairments in the Greater Gulf Region: Protocol for a Retrospective Real-World Data StudyAbdulnaser Nourallah, Abdulrahman Alshehri, Ayman Alhejazi, et al.
Small (Weinheim an Der Bergstrasse, Germany)|October 5, 2023
Wafer-Scale Two-Dimensional Semiconductors for Deep UV SensingMustaqeem Shiffa, Benjamin T Dewes, Jonathan Bradford, et al.
Diabetologia|September 10, 2013
Trans-ethnic fine mapping identifies a novel independent locus at the 3' end of CDKAL1 and novel variants of several susceptibility loci for type 2 diabetes in a Han Chinese populationJane Z Kuo, Wayne Huey-Herng Sheu, Themistocles L Assimes, et al.
Leukemia|April 15, 2018
Treatment approaches and outcomes in plasmacytomas: analysis using a national datasetGaurav Goyal, Adam C Bartley, Shealeigh Funni, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 18, 2026
Ixazomib, Cyclophosphamide, and Dexamethasone (ICd), With or Without Daratumumab in Relapsed Multiple MyelomaShaji Kumar, Betsy Knopf, Erik Asmus, et al.
Blood Advances|July 1, 2025
From CyBorD to dara-CyBorD, ASCT utilization trends in AL amyloidosis: a 15-year analysisEli Muchtar, Angela Dispenzieri, Francis K Buadi, et al.
Blood Advances|June 25, 2026
Clinical Course, Risk Factors, and Therapeutic Response in Multiple Myeloma with Central Nervous System InvolvementAlexander Xiao, Saurabh S Zanwar, Yi Lin, et al.
Pageof 32